Low desire & intimacy
I love my partner. I just don’t want sex like I used to.
You don’t necessarily want more sex. You want to want it again.
You want attraction to feel like attraction. Touch to feel like touch. And intimacy to stop feeling like something you have to remember to do. When the relationship is still there but the desire isn’t, another date night may not be the whole answer.
Start My Private EvaluationPrescription treatments are available only after evaluation and approval by a licensed healthcare provider. No automatic prescription.
In short
Low sexual desire does not have a single cause, so EmbraceHealth.ai begins with a private clinician evaluation rather than a product. A clinician reviews when the change started, whether desire is low generally or only in certain situations, your medications, hormonal and medical factors, pain, stress, mental health, relationship factors and cardiovascular history, then determines whether prescription treatment is appropriate at all. Two options may be considered. PT-141, also known as bremelanotide, is a melanocortin receptor agonist that acts on receptors in the central nervous system rather than on blood flow, priced at $199 for one month or $549 for three; bremelanotide is the active ingredient in FDA-approved Vyleesi, but compounded PT-141 is not itself FDA approved. Compounded oxytocin nasal spray is $129 for one month or $349 for three, and should not be represented as proven to increase libido or repair relationships — controlled human research on intranasal oxytocin and sexual function remains limited and mixed. No outcome is guaranteed.
“Nothing is wrong between us. So why don’t I want sex?”
That is what makes low desire so frustrating.
You can love your partner. Still find them attractive. Still enjoy being close to them. And still notice that something has changed.
You don’t initiate. You don’t think about sex very often. When your partner reaches for you, sometimes you feel pressure before you feel excitement.
Eventually they notice. Then come the questions.
“Are you still attracted to me?”
“Is something wrong?”
“Why don’t you ever initiate anymore?”
And you don’t have a good answer. Because sometimes you don’t know either.
Why the usual fixes can feel like they miss the point
You’ve probably heard some version of this already. Schedule date night. Get away for the weekend. Buy something sexy. Try a supplement. Use a toy. Relax more. Have sex more often and maybe the desire will come back. Communicate better.
Those things can absolutely matter. But they are not interchangeable with sexual desire.
A romantic dinner cannot diagnose medication-related sexual effects. A vacation cannot identify a hormonal issue. Lingerie cannot tell you whether pain, stress, relationship dynamics, menopause, mental health, another medication or a sexual-desire disorder is contributing. And “just do it more often” can make intimacy feel even more like an obligation.
Low desire does not have one cause. That is why Embrace starts with the person, not the prescription.
What people actually want back
Not performance. This.
“I want to want sex again.”
Not perform because I feel obligated. Not check another box. Actually want it.
“I want my partner to stop thinking it’s them.”
When desire disappears, the person you love can start wondering whether they are the problem. Sometimes they aren’t.
“I want affection without immediately feeling pressure.”
A hug should be allowed to be a hug. A kiss shouldn’t automatically feel like the beginning of a negotiation.
“I want to feel like that part of me still exists.”
Low desire can feel less like a bedroom problem and more like losing a piece of yourself.
“I don’t want us to wake up one day and realize we’ve become roommates.”
Intimacy can change slowly. So slowly that neither person realizes how much distance has developed until it has become normal.
A different approach to low desire
Instead of assuming you need another supplement or another relationship lecture, your Embrace consultation looks at the bigger picture.
Your clinician can review factors such as:
- When the change started
- Whether desire is low generally or only in certain situations
- Medications that may affect sexual function
- Medical and hormonal factors
- Pain or discomfort
- Stress and mental health
- Relationship factors
- Your cardiovascular history and other safety considerations
- Whether prescription treatment is medically appropriate
Then treatment can be matched to what is actually going on. No automatic prescription. No pretending every low-libido problem is the same.
Two different conversations
These experiences overlap, but they are not identical — and Embrace should not pretend every intimacy problem has the same prescription answer. Your clinician determines which, if either, is appropriate.
Path one — desire
“I want to want sex again.”
A lot of sexual-health treatment revolves around physical performance. Blood flow. Erections. Lubrication. Duration. Those things matter. But someone can be physically capable of having sex and still say: I just don’t want it.
PT-141, also known as bremelanotide, is a melanocortin receptor agonist. It interacts with melanocortin receptors in the central nervous system, including MC4 receptors. The exact mechanism by which FDA-approved bremelanotide improves HSDD is not fully understood.
That makes the treatment conversation fundamentally different from asking whether your body can physically perform. The question becomes: what happened to the desire?
PT-141 Injection
Melanocortin receptor agonist
From $199
$199 for 1 month. $549 for 3 months — about $183/month, saving $48.
A desire-focused prescription pathway rather than a blood-flow medication. Prescription eligibility and use depend on your individual clinical situation.
- Acts centrally, not on blood flow
- Not appropriate with uncontrolled hypertension or known cardiovascular disease
- Nausea is a common adverse effect
- Compounded PT-141 is not FDA approved
Path two — connection
“I miss feeling close.”
Oxytocin is sometimes called the “bonding hormone” because it participates in complex social, reproductive and behavioral processes. That nickname makes for great internet marketing.
It does not mean a nasal spray has been proven to make someone fall back in love, repair a relationship, or reliably increase libido. Human research on intranasal oxytocin and sexual function remains limited and mixed. A small couples study found some differences in post-orgasm experience and partner interaction, but no improvement in sexual drive or conventional measures of arousal. A separate randomized trial in women found that oxytocin did not outperform placebo on the primary sexual-function measures.
That is why Embrace does not sell it as a magic “love spray.” A clinician can determine whether compounded oxytocin is an appropriate option for your individual situation — with clear information about what the evidence does and does not show.
Oxytocin Nasal Spray
Compounded intranasal formulation
From $129
$129 for 1 month. $349 for 3 months — about $116/month, saving $38.
Offered as a clinician-evaluated option, not a guaranteed intimacy treatment. If you are looking for a guaranteed libido increase, this is not it.
- Not FDA approved for low libido or pair bonding
- Evidence on sexual function is limited and mixed
- Not couples therapy and not a relationship cure
- Compounded medications are not FDA reviewed
“I’ve already tried everything.”
Maybe you have. Supplements. Date nights. Vacations. Lingerie. Toys. Therapy. Hormones. Talking about it. Not talking about it. Scheduling sex. Waiting for the mood to return.
That doesn’t mean another prescription will automatically solve the problem. It means the next step should not be another guess.
Low desire can have multiple causes. A medical consultation gives you an opportunity to sort through those possibilities and determine whether prescription treatment belongs in the plan at all.
“How do I know this isn’t another libido gimmick?”
You shouldn’t trust a treatment simply because someone calls it a libido booster. Ask harder questions.
What medication am I actually getting? How is it supposed to work? What evidence supports it? What are the risks? Is this FDA approved for my situation, FDA approved for another indication, or compounded and off-label? Who determines whether I should take it? What happens if I shouldn’t?
Those are exactly the questions a legitimate prescription process should answer. Embrace doesn’t need you to believe a miracle claim. We need enough information for a licensed clinician to decide whether treatment makes sense for you.
“Why would I spend $129 or $199 on this?”
Because you’re not buying a bottle and hoping for the best. You’re pursuing a prescription option for a problem that may be affecting something much bigger than sex.
But price matters. So does whether treatment is appropriate. And no prescription is worth buying simply because you’ve reached the end of your patience.
Start with the evaluation. Understand your options. Then decide.
“I’m worried about side effects.”
Good. You should ask.
PT-141 is not appropriate for everyone. FDA-approved bremelanotide can temporarily increase blood pressure and reduce heart rate. Its labeling contraindicates use in people with uncontrolled hypertension or known cardiovascular disease. Nausea is also common.
Your medical history matters. Your medications matter. Your blood pressure matters. That is why this is a clinician-guided treatment decision, not an impulse purchase.
“What if my relationship is actually the problem?”
Then a medication should not be used to pretend it isn’t.
Relationship conflict, pain, depression, medication effects, hormonal changes and other medical or psychological issues can all influence sexual desire. In fact, FDA-approved bremelanotide’s indication specifically excludes low desire primarily attributable to a relationship problem, medical or psychiatric condition, or the effects of a medication or drug.
Sometimes the right answer is treatment. Sometimes it isn’t. The point is to stop guessing.
Common questions
Why has my sex drive changed when nothing is wrong in my relationship?
Low desire does not have one cause. Medication effects, hormonal changes, stress, pain, mental health, sleep, life stage, relationship dynamics, other medical conditions or a diagnosable sexual desire disorder can all contribute. You can love your partner, still find them attractive, and still notice something changed. That is exactly why the evaluation looks at the whole picture rather than assuming one explanation.
What prescription options does Embrace offer for low desire?
Two, and they address different problems. PT-141, also known as bremelanotide, is a melanocortin receptor agonist studied for hypoactive sexual desire disorder — a desire-focused pathway. Compounded oxytocin nasal spray is offered as a clinician-evaluated intimacy option, with the important caveat that controlled research has not consistently shown it increases sexual desire or arousal. Which, if either, is appropriate is a clinical decision.
Is low desire the same problem as erectile dysfunction?
No. Someone can be physically capable of having sex and still have very little interest in initiating it. Traditional ED treatment asks whether your body can respond. A desire-focused evaluation asks whether you want sex in the first place. Solving the wrong problem is one reason people become frustrated with sexual health treatment.
What if my relationship is actually the problem?
Then a medication should not be used to pretend it isn’t. Relationship conflict, pain, depression, medication effects, hormonal changes and other medical or psychological issues can all influence desire. FDA-approved bremelanotide’s indication specifically excludes low desire primarily attributable to a relationship problem, a medical or psychiatric condition, or the effects of a medication or drug. Sometimes the right answer is treatment. Sometimes it isn’t.
Are these treatments FDA approved?
Bremelanotide is the active ingredient in FDA-approved Vyleesi, which is indicated for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women. If the PT-141 dispensed is compounded, that compounded medication itself is not FDA approved. Compounded intranasal oxytocin is not FDA approved for low libido, pair bonding or relationship treatment. Compounded drugs do not undergo FDA premarket review for safety, effectiveness or quality.
Can these treatments repair my relationship?
No medication should be advertised as repairing a relationship. Low desire may be one factor affecting intimacy, but relationship difficulties often have several causes. Oxytocin in particular should not be represented as proven to restore pair bonding or repair relationships.
Will everyone qualify?
No. PT-141 is not appropriate for everyone — FDA-approved bremelanotide is contraindicated in people with uncontrolled hypertension or known cardiovascular disease and is not recommended for people at high cardiovascular risk. Your medical history, medications and blood pressure all matter, which is why this is a clinician-guided decision rather than an impulse purchase.
Does Embrace guarantee results?
No. Treatment response varies, and no particular sexual, emotional or relationship outcome is guaranteed.
You don’t need to promise your partner more sex.
You don’t need to force yourself to “try harder.” And you don’t need to accept every claim made by another libido product.
But if you’ve been quietly wondering why you don’t want sex anymore, that question probably deserves a real answer. Because doing nothing is still a decision.
Months can turn into years. Avoiding initiation can become normal. Your partner can learn to stop asking. You can both get very good at living around the subject. And what started as “we haven’t had sex much lately” can eventually become: when did we become roommates?
Start My Private EvaluationA licensed clinician will review your medical history and determine whether prescription treatment is appropriate. No automatic prescription. No miracle promises. Just a more informed next step.
Clinical disclosure
Prescription treatments are available only after evaluation and approval by a licensed healthcare provider. Treatment selection depends on individual medical history, symptoms, medications, contraindications and clinical judgment.
Bremelanotide is the active ingredient in FDA-approved Vyleesi. FDA-approved Vyleesi is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder in premenopausal women when the low desire is not caused by a coexisting medical or psychiatric condition, relationship problem, or the effects of medication or drugs. The precise mechanism by which bremelanotide improves HSDD is unknown. FDA-approved Vyleesi can temporarily increase blood pressure and reduce heart rate and is contraindicated in people with uncontrolled hypertension or known cardiovascular disease.
Compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or manufacturing quality before marketing in the same manner as FDA-approved drugs. Individual compounded formulations, routes, doses and clinical uses may differ from FDA-approved products.
Intranasal oxytocin should not be represented as proven to restore pair bonding, repair relationships or reliably increase sexual desire. Published human evidence concerning sexual function and partner interaction remains limited and mixed.
Results vary. Prescription treatment is not appropriate for everyone. This information is educational and is not a substitute for individualized medical advice.